🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to identify preventive treatments that can min...
Status
Recruiting
Location
University of California San Francisco
Start Date
2024-08-26
Trial ID
NCT06500884
Treatments Being Tested
This phase II trial studies how well daratumumab, azacitidine, and dexameth...
Status
Terminated
Location
University of California, San Francisco
Start Date
2020-11-30
Trial ID
NCT04407442
Treatments Being Tested
The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-06-12
Trial ID
NCT04181827
Treatments Being Tested
The purpose of this study is to show that subcutaneous (SC) administration ...
Status
Completed
Location
Dana Farber Cancer Institute
Start Date
2017-10-27
Trial ID
NCT03277105
The DARA-MVI Study is a prospective, randomized, controlled, open-label tri...
Status
Active Not Recruiting
Location
Transplant-nephrology department
Start Date
2025-11-01
Trial ID
NCT07274462
Treatments Being Tested
Multiple myeloma is a type of blood cancer that can come back even after ef...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09
Trial ID
NCT07740486
Treatments Being Tested
The purpose of this study is to evaluate the effects of the addition of dar...
Status
Completed
Location
Antwerpen
Start Date
2017-06-14
Trial ID
NCT03180736
Treatments Being Tested
Multiple myeloma (MM) is a neoplastic disease deriving from an abnormal pro...
Status
Active Not Recruiting
Location
Dipartimento di Biotecnologie Molecolari e Scienze per la Salute
Start Date
2019-01-03
Trial ID
NCT03829371
Treatments Being Tested
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer i...
Status
Recruiting
Location
City of Hope National Medical Center /ID# 273132
Start Date
2025-06-30
Trial ID
NCT06892522
The primary purpose of this study is to compare the efficacy of daratumumab...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2017-11-30
Trial ID
NCT03234972
Treatments Being Tested